Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
AbbVie (GB:0QCV)
LSE:0QCV
AbbVie (0QCV) Stock Price & Analysis
2 Followers
0QCV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$131.61 - $169.42
Previous Close$157.58
Volume138.32K
Average Volume (3M)136.17K
Market Cap
$279.57B
Enterprise Value$333.50B
Total Cash (Recent Filing)$9.23B
Total Debt (Recent Filing)$63.27B
Price to Earnings (P/E)23.8
Beta0.34
Next Earnings
Apr 27, 2023EPS Estimate
$2.56Next Dividend Ex-Date
Apr 13, 2023Dividend Yield
5.78 (3.67%)Share Statistics
EPS (TTM)6.63
Shares Outstanding1,764,141,787
10 Day Avg. Volume167
30 Day Avg. Volume136,166
Standard Deviation0.10
R-Squared0.00891
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-3.39
Price to Sales (P/S)2.42
Price to Cash Flow (P/CF)11.30
P/FCF Ratio20.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.74
Enterprise Value/Gross Profit8.21
Enterprise Value/Ebitda13.80
Forecast
1Y Price Target
$163.23Price Target Upside3.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
AbbVie News
0QCV FAQ
What was AbbVie’s price range in the past 12 months?
AbbVie lowest stock price was $131.61 and its highest was $169.42 in the past 12 months.
What is AbbVie’s market cap?
Currently, no data Available
When is AbbVie’s upcoming earnings report date?
AbbVie’s upcoming earnings report date is Apr 27, 2023 which is in 26 days.
How were AbbVie’s earnings last quarter?
AbbVie released its earnings results on Feb 09, 2023. The company reported $3.6 earnings per share for the quarter, beating the consensus estimate of $3.561 by $0.039.
Is AbbVie overvalued?
According to Wall Street analysts AbbVie’s price is currently Undervalued.
Does AbbVie pay dividends?
AbbVie pays a Quarterly dividend of $1.48 which represents an annual dividend yield of 3.67%. See more information on AbbVie dividends here
What is AbbVie’s EPS estimate?
AbbVie’s EPS estimate is $2.56.
How many shares outstanding does AbbVie have?
AbbVie has 1,769,400,000 shares outstanding.
What happened to AbbVie’s price movement after its last earnings report?
AbbVie reported an EPS of $3.6 in its last earnings report, beating expectations of $3.561. Following the earnings report the stock price went up 2.259%.
Which hedge fund is a major shareholder of AbbVie?
Among the largest hedge funds holding AbbVie’s share is Diamond Hill Capital Management Inc. It holds AbbVie’s shares valued at 218M.
---
AbbVie Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$163.23 (3.59% Upside)
$163.23 (3.59% Upside)
Blogger Sentiment
Bullish
GB:0QCV Sentiment 89%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $8.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.13%
12-Months-Change
Fundamentals
Return on Equity
72.16%
Trailing 12-Months
Asset Growth
-5.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AbbVie
AbbVie, Inc. is a biopharmaceutical company focused on key therapeutic areas like immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
---
---